Topics

Clover Biopharmaceuticals Company Profile

05:46 EDT 20th September 2019 | BioPortfolio

Clover Biopharmaceuticals is a global, clinical-stage, research-based biotechnology company focused on discovering, developing and commercializing transformative biologic therapies, with a focus on oncology and autoimmune diseases. Clover is utilizing its proprietary Trimer-Tag© technology platform to develop novel biologics targeting trimerization-dependent pathways. Additionally, Clover is leveraging its in-house cGMP biomanufacturing capabilities to develop select biosimilars. For more information, please visit our website: www.cloverbiopharma.com.


News Articles [222 Associated News Articles listed on BioPortfolio]

Clover Therapeutics Launches With Eye on Age-Related Ocular Diseases

Clover Therapeutics, which sprung out of Clover Health, is supported by a number of biotech and pharma veterans, including Pfizer veteran Cheng Zhang, who is heading up therapeutics, and Genentech vet...

Sichuan Clover Doses First Patient in China Trial of Novel Cancer Biologic

Sichuan Clover Biopharma has dosed the first patient in a China Phase I trial of its fully-human TRAIL-Trimer fusion protein in cancer patients with peritoneal carcinomatosis. Clover described PC as a...

Clover Biopharmaceuticals Receives NMPA Approval for SCB-313 (TRAIL-Trimer) to Initiate Clinical Trials in China

Clover Biopharmaceuticals, a biotechnology company focused on developing novel and transformative biologic therapies, today announced it has received Clinical Trial Application (C...

Clover Biopharmaceuticals Doses First Patient in Phase I Study of SCB-313 in China for Peritoneal Carcinomatosis

Clover Biopharmaceuticals, a biotechnology company focused on developing novel and transformative biologic therapies, today announced that the first patient was dosed in a Phase I trial of SCB-313, a...

SK Biopharmaceuticals-Arvelle partner on epilepsy drug cenobamate in Europe

South Korea-based SK Biopharmaceuticals and Swiss Arvelle Therapeutics have signed an exclusive licensing agreement to develop and commercialise SK Biopharmaceuticals’...Read More... The post SK Bio...

NGM Biopharmaceuticals' IPO brings in $106.7M

NGM Biopharmaceuticals' initial public offering raised $106.7 million.  -More- 

Lundbeck to buy Alder BioPharmaceuticals for £1.56bn

Alder BioPharmaceuticals is involved in the discovery, development and commercialisation of novel therapeutic antibodies. As per terms of the deal, Lundbeck will begin a tender offer for all The post...

How patient data will drive Clover Health’s new R&D unit

Drugs and Medications [4 Associated Drugs and Medications listed on BioPortfolio]

Cubicin [oso biopharmaceuticals manufacturing, llc]

Drug Listing for CDF Product Code

Na [nabi biopharmaceuticals]

NA

Kit for the preparation of lymphoseek (technetium tc 99m tilmanocept) [navidea biopharmaceuticals, inc.]

These highlights do not include all the information needed to use LYMPHOSEEK safely and effectively. See full prescribing information for LYMPHOSEEK. Lymphoseek (technetium Tc 99m tilmanocept) injecti...

Kybella [kythera biopharmaceuticals inc.]

These highlights do not include all the information needed to use KYBELLA safely and effectively. See full prescribing information for KYBELLA .         KYBELLA ( d eoxycholic acid )   injectio...

PubMed Articles [48 Associated PubMed Articles listed on BioPortfolio]

Dynamics of the isoflavone metabolome of traditional preparations of Trifolium pratense L.

The flowering tops of Trifolium pratense L., popularly known as red clover, are used in ethnic Western and Traditional Chinese medicine, in a variety of preparations, including infusions, decoctions a...

ELEVATION OF CONDENSED TANNINS IN THE LEAVES OF Ta-MYB14-1 WHITE CLOVER (Trifolium repens L.) OUTCROSSED WITH HIGH ANTHOCYANIN LINES.

Condensed tannins (CT) are highly desirable in forage as they sequester dietary protein, reducing bloat and methane emissions in ruminants. However, the widely used forage legume white clover (Trifoli...

Antibody-cytokine fusion proteins: a novel class of biopharmaceuticals for the therapy of cancer and of chronic inflammation.

Antibody-cytokine fusion proteins represent a novel class of biopharmaceuticals, with the potential to increase the therapeutic index of cytokine 'payloads' and to promote leukocyte infiltration at th...

Precise exchange of HC-Pro cistron between soybean mosaic virus and clover yellow vein virus: Impact on virus viability and host range specificity.

Soybean mosaic virus and Clover yellow vein virus are two definite species of the genus Potyvirus within the family of Potyviridae. Soybean mosaic virus-N (SMV-N) is well adapted to cultivated soybean...

Co-delivery of TRAIL and siHSP70 using hierarchically modular assembly formulations achieves enhanced TRAIL-resistant cancer therapy.

The combined therapy of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and heat shock protein 70-targeting siRNA (siHSP70) has shown an improved anti-tumor effect on TRAIL-resistant t...

Clinical Trials [11 Associated Clinical Trials listed on BioPortfolio]

The Bioavailability of Red Clover Isoflavones

Previous literature has shown that the molecular form of isoflavones (as aglycones or glycosides) and food matrices can influence the bioavailability of these compounds in humans and hence...

Use of Black Cohosh and Red Clover for the Relief of Menopausal Symptoms

This Phase II study, a follow-up to a Phase I trial in normal volunteers, will determine the efficacy of black cohosh and red clover for the relief of menopausal symptoms. It will also as...

Alternative Treatments for Menopausal Women

To investigate the reported health benefits (lipid profile, inflammatory factors, cardiovascular status and bone density) of a novel, phytoestrogen rich, Red Clover treatment on women suff...

Red Clover and Lifestyle Changes to Contrast Menopausal Symptoms in Premenopausal Breast Cancer Patients Given Tamoxifen

A prospective double-blind randomized trial of red clover extract (Promensil) vs placebo in surgically-treated premenopausal women with estrogen receptor-positive breast cancer taking tamo...

Single-Dose Study of Black Cohosh and Red Clover

This Phase I study will assess the pharmacokinetics of two botanicals, Trifolium pratense (red clover) and Cimicifuga racemosa (black cohosh). Participants will receive a single dose of o...

Companies [200 Associated Companies listed on BioPortfolio]

Clover Biopharmaceuticals

Clover Biopharmaceuticals is a global, clinical-stage, research-based biotechnology company focused on discovering, developing and commercializing transformative biologic therapie...

Clover Sonoma

Third-generation family-owned and operated, Clover Sonoma is recognized as a leader at the forefront of the dairy industry. The Petaluma-based company in Northern California’s beautiful Sonoma C...

Clover Stornetta Farms

Celebrating its centennial anniversary, third-generation family owned and operated Clover Stornetta Farms is recognized as a leader at the forefront of the dairy industry. The Pet...

/alert Marketing

Providing the best media for delivery of health care information and education to professionals and consumers.

Itero Biopharmaceuticals, Inc.

Itero Biopharmaceuticals, Inc. is a specialty biopharmaceutical company focused on the development and commercialization of protein therapeutics that offer significant clinical an...

More Information about "Clover Biopharmaceuticals" on BioPortfolio

We have published hundreds of Clover Biopharmaceuticals news stories on BioPortfolio along with dozens of Clover Biopharmaceuticals Clinical Trials and PubMed Articles about Clover Biopharmaceuticals for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Clover Biopharmaceuticals Companies in our database. You can also find out about relevant Clover Biopharmaceuticals Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks



Searches Linking to this Company Record